Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda E Clements

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Osteoporosis Reports|August 31, 2019
Breast Cancer Dormancy in BoneMiranda E Clements, Rachelle W Johnson
Oncogene|October 23, 2019
PREX1 drives spontaneous bone dissemination of ER+ breast cancer cellsMiranda E Clements, Rachelle W Johnson
JBMR Plus|March 20, 2023
Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate TherapyMiranda E Clements, Lauren Holtslander, Joshua R Johnson, et al.
Journal of Bone Oncology|December 22, 2021
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancerCourtney M Edwards, Miranda E Clements, Lawrence A Vecchi, et al.
Communications Biology|September 24, 2021
Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific mannerVera M Todd, Lawrence A Vecchi, Miranda E Clements, et al.
Oncogene|July 11, 2021
HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancerMiranda E Clements, Lauren Holtslander, Courtney Edwards, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Osteoporosis Reports|August 31, 2019
Breast Cancer Dormancy in BoneMiranda E Clements, Rachelle W Johnson
Oncogene|October 23, 2019
PREX1 drives spontaneous bone dissemination of ER+ breast cancer cellsMiranda E Clements, Rachelle W Johnson
JBMR Plus|March 20, 2023
Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate TherapyMiranda E Clements, Lauren Holtslander, Joshua R Johnson, et al.
Journal of Bone Oncology|December 22, 2021
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancerCourtney M Edwards, Miranda E Clements, Lawrence A Vecchi, et al.
Communications Biology|September 24, 2021
Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific mannerVera M Todd, Lawrence A Vecchi, Miranda E Clements, et al.
Oncogene|July 11, 2021
HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancerMiranda E Clements, Lauren Holtslander, Courtney Edwards, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Pageof 1